Search
Now showing items 1-6 of 6
Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study
(Public Library of Science, 2018)
In Kenya, noncommunicable diseases (NCDs) account for 27% of all deaths. Adult Kenyans
have an 18% chance of dying prematurely from cancers, diabetes, cardiovascular diseases
or chronic respiratory diseases. A Novartis ...
Access to medicines for asthma, diabetes and hypertension in eight counties of Kenya
(Wiley, 2018)
OBJECTIVES: To assess access to noncommunicable diseases (NCD) medicines in Kenya for patients diagnosed and prescribed treatment for asthma, diabetes and hypertension.
METHODS: Households in eight purposively chosen ...
Study protocol for a cluster-randomised controlled trial of an NCD access to medicines initiative: evaluation of Novartis Access in Kenya
(BMJ Publishing Group, 2016)
INTRODUCTION: Novartis recently launched Novartis
Access, an initiative to provide a basket of reduced
price medicines for non-communicable diseases
(NCDs) to be sold through the public and private nonprofit
sectors ...
Probability and amount of medicines expenditure according to health insurance status in Kenya: A household survey in eight counties
(Wiley, 2021)
National and county governments in Kenya
have introduced various health insurance schemes to protect households against financial hardship as a result of large
health expenditure. This study examines the relationship
between ...
Comparative analysis of essential medicines for cardiovascular diseases in countries of the WHO Eastern Mediterranean Region
(World Health Organization, 2018)
Adequate access to essential medicines for cardiovascular disease is necessary to address the high
cardiovascular disease burden in countries of the Eastern Mediterranean Region of the World Health Organization (WHO). ...
Willingness to pay brand premiums for generic medicines in Kenya: A bidding game experiment
(John Wiley and Sons Ltd, 2023)
Background: Recent growth in the market share of higher priced branded generic medicines in low- and middle-income countries (LMICs) has raised concerns around affordability and access. We examined consumer willingness to ...